Markets:

Overview

News

Currencies

International

Treasuries

Agios Pharmaceuticals, Inc. - Common Stock (NQ:AGIO)

26.93 -0.14 (-0.54%)

Streaming Delayed Price Updated: 10:51 AM EDT, Apr 21, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Agios Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Wondering what's happening in today's pre-market session? ↗

November 19, 2025

Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 19, 2025

Via Benzinga

Agios Pharmaceuticals Inc (NASDAQ:AGIO) Tops Q3 2025 Estimates with Strong Revenue Beat ↗

October 30, 2025

Agios Pharma's Q3 2025 results beat revenue and EPS estimates, driving a positive market reaction and highlighting strong commercial performance.

Via Chartmill

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Earnings Outlook For Agios Pharmaceuticals ↗

October 29, 2025

Via Benzinga

Agios Retail Buzz Surges On Saudi Thalassemia Nod As Retail Hails ‘Incredible Recovery’ Despite FDA Concerns ↗

August 05, 2025

Via Stocktwits

Earnings Scheduled For July 31, 2025 ↗

July 31, 2025

Via Benzinga

Earnings Scheduled For May 1, 2025 ↗

May 01, 2025

Via Benzinga

An Overview of Agios Pharmaceuticals's Earnings ↗

April 30, 2025

Via Benzinga

Inhibrx Stock Soars on Breakthrough Chondrosarcoma Trial Results: A New Dawn for Rare Cancer Treatment

October 24, 2025

San Diego, CA – October 24, 2025 – Inhibrx (NASDAQ: INBX) shares have surged dramatically, skyrocketing over 70% in pre-market and after-hours trading, following the announcement of overwhelmingly...

Via MarketMinute

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO

September 24, 2025

From Pomerantz LLP

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 23, 2025

Via Benzinga

Earnings Scheduled For February 13, 2025 ↗

February 13, 2025

Via Benzinga

Analyst Ratings For Agios Pharmaceuticals ↗

December 10, 2024

Via Benzinga

AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm

September 15, 2025

From Schall Law Firm

Via Business Wire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO

September 14, 2025

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO

September 10, 2025

From Pomerantz LLP

Via GlobeNewswire

Agios Pharma Stock Slumped 15% Today But Company Remains Top Pick For This Analyst – Find Out More ↗

September 04, 2025

While the FDA was originally expected to decide on the company’s application for Pyrukynd in treating thalassemia by September 7, its decision is now expected by December 7.

Via Stocktwits

FDA Delays Decision On Agios Pharmaceuticals' Blood Disorder Drug For Expanded Use ↗

September 04, 2025

Agios' Pyrukynd FDA review for thalassemia delayed to Dec. 7, 2025, after REMS submission addressing potential liver injury risk.

Via Benzinga

Top movers in Thursday's pre-market session ↗

September 04, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 04, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 04, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Monday's session. ↗

August 04, 2025

Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

Via Chartmill

What's going on in today's pre-market session ↗

August 04, 2025

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 04, 2025

Via Benzinga

Agios (AGIO) Q2 Revenue Jumps 45% ↗

August 01, 2025

Via The Motley Fool

Topics Intellectual Property

Agios Pharmaceuticals Inc (NASDAQ:AGIO) Reports Mixed Q2 2025 Results: Revenue Beat but Wider EPS Loss ↗

July 31, 2025

Agios Pharmaceuticals (AGIO) reported Q2 2025 revenue of $12.46M, beating estimates, but EPS of -$1.93 missed forecasts. Shares fell 10.66% pre-market amid mixed financials and ongoing rare disease...

Via Chartmill

Agios Pharmaceuticals Reveals Encouraging Data From Rare Blood Disorder Study In Younger Patients Aged Below 18 Years ↗

February 13, 2025

Agios' mitapivat met its primary endpoint in a Phase 3 trial for PK deficiency in children. The company plans a marketing application based on the results.

Via Benzinga

Tesla, Micron, Broadcom, MARA Holdings And Other Big Stocks Moving Higher On Monday ↗

December 16, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.